Apimeds Pharmaceuticals US, Inc.

APUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B4 May 9, 2025 PROSPECTUS
3 May 8, 2025 PRIMARY DOCUMENT
3 May 8, 2025 PRIMARY DOCUMENT
3 May 8, 2025 PRIMARY DOCUMENT
3 May 8, 2025 PRIMARY DOCUMENT
3 May 8, 2025 PRIMARY DOCUMENT
3 May 8, 2025 PRIMARY DOCUMENT
3 May 8, 2025 PRIMARY DOCUMENT
3 May 8, 2025 PRIMARY DOCUMENT
3 May 8, 2025 PRIMARY DOCUMENT
EFFECT May 5, 2025
CORRESP May 5, 2025
CORRESP May 5, 2025
UPLOAD May 5, 2025
POS AM May 2, 2025 POST-EFFECTIVE AMENDMENT
10-K/A May 2, 2025 AMENDMENT NO. 1 TO FORM 10-K
CORRESP May 1, 2025
CORRESP May 1, 2025
POS AM May 1, 2025 POST-EFFECTIVE AMENDMENT
UPLOAD May 1, 2025
UPLOAD Apr 30, 2025
POS AM Apr 17, 2025 POST-EFFECTIVE AMENDMENT
10-K Apr 15, 2025 ANNUAL REPORT
8-K Apr 15, 2025 CURRENT REPORT
NT 10-K Mar 31, 2025 NOTIFICATION OF LATE FILING
← Newer Page 4 of 6 · 127 filings Older →